Medical News

RSS

Radiologist reports 90% radiation reduction in new cardiac CT scanners

Dr. James Earls, a radiologist from Fairfax Radiological Consultants in suburban Washington, D.C. will present the findings of a study that shows a 90 percent reduction in the amount of radiation heart patients received from CT scans compared to scans performed two years ago.

2 Dec 2009

NAF and Bristol-Myers Squibb take initiative to launch 'Positive Charge'

The National AIDS Fund (NAF) and Bristol-Myers Squibb Company announced today their intention to launch “Positive Charge,” a new multiyear initiative aimed at helping to break down the barriers that prevent people living with HIV from receiving HIV care, treatment and necessary support.

2 Dec 2009

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor may increase the incidence of autism-spectrum disorders, psychiatric pathology, cognitive problems and poor school performance in their children, according to a new study published in the December 2009 issue of the American Journal of Obstetrics & Gynecology.

2 Dec 2009

NuGEN Technologies launches its next generation Ovation RNA-Seq System

NuGEN Technologies, Inc., a pace-setter in genomic sample preparation, enters the next generation sequencing (NGS) market today with its Ovation RNA-Seq System, a revolutionary method of sample preparation that broadens research horizons with a more comprehensive representation of the transcriptome created from samples of a few hundred picograms.

2 Dec 2009

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.

2 Dec 2009

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.

2 Dec 2009

Educational resource guide about pharmaceutical industry practices released

The educational resource, "The Value of Medicine, Improving Health... Improving Life," created by Lilly USA (NYSE: LLY), is now available at www.lillyforbetterhealth.com/value_of_medicine.jsp. The booklet supports Lilly's commitment to providing "Answers That Matter" and encourages an open dialogue with patients, providers, payers and the public about pharmaceutical industry practices.

2 Dec 2009

Health Sciences Group announces positive feedback from Medical Marijuana

Health Sciences Group has had positive feedback from Medical Marijuana, Inc. (MJNA) about the expansion and revenue producing areas allowed within the United States pertaining to marijuana collectives versus marijuana dispensaries.

2 Dec 2009

Development of novel virus can lead to new therapeutic strategy to combat cancer

Ohio State University cancer researchers have developed a tumor-attacking virus that both kills brain-tumor cells and blocks the growth of new tumor blood vessels.

2 Dec 2009

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

To address the emergence of the synthetic biology industry and to promote its potential, a group of individuals and companies announced the formation of the Synthetic Biology Industry Association (SynBIA) in Cambridge, Massachusetts last week.

2 Dec 2009

Study reveals current cleaning methods can do more harm than good to school environments

A study performed by Coverall Health-Based Cleaning System(SM), a leading franchisor of commercial cleaning businesses, revealed that methods used by outside cleaning contractors could actually do more harm than good to indoor environments.

2 Dec 2009

Cyber Monday was the best day ever, announces drugstore.com

drugstore.com, inc., a leading online retailer of health, beauty, vision, and pharmacy products, today announced that Cyber Monday was its best day ever as customer orders were the highest in company history.

2 Dec 2009

$Careful diagnosis can help avoid long-term disabilities associated with uncommon fractures$

Careful diagnosis can help avoid long-term disabilities associated with uncommon fractures

Located in areas of the foot that can be hard to visualize with X-rays and other imaging techniques, injuries to the ankle area of the foot are the most frequently misdiagnosed of all foot fractures. Delayed diagnosis can have serious consequences, sometimes leading to permanent disability.

2 Dec 2009

Genzyme ships vials of newly produced Cerezyme

Genzyme Corporation announced today that it has begun shipping vials of newly produced Cerezyme® (imiglucerase for injection) manufactured at its Allston Landing plant.

2 Dec 2009

Roche announces results of phase III taspoglutide study in diabetes patients

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen’s research and developed by Roche.

2 Dec 2009

Pharmacists provide strategies to minimize disruption on common prescription drugs

Seniors may find that many common prescription drugs that Medicare Part D has covered for years may suddenly be denied due to a new policy being implemented by the Centers for Medicare and Medicaid Services (CMS).

2 Dec 2009

Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

Increasing genomic knowledge will lead to the development of improved therapies to treat lifestyle disorders. In the near future, the European lifestyle disorders therapeutics market is set to witness enhanced therapies and novel drugs to treat such conditions and reduce the risk of co-morbidities.

2 Dec 2009

Bioactive sponge to eliminate normally fatal tumors

InCytu Incorporated, a therapeutic device engineering company, announced the details of its Cellarium™ Cancer Vaccine program. Cellarium™ is a small bioactive sponge which regulates dendritic cells and T-cells to eliminate normally fatal tumors in a preclinical model of late stage melanoma. The details of such a promising new vaccine were published for the first time in Science’s Translational Medicine Journal.

2 Dec 2009

Infections remain a common problem in ICU patients

An international study that examined the extent of infections in nearly 1,300 intensive care units (ICUs) in 75 countries found that about 50 percent of the patients were considered infected, with infection associated with an increased risk of death in the hospital, according to a study in the December 2 issue of JAMA.

2 Dec 2009

Occult lesions identified with BSGI can be localized using multi-modality imaging for needle biopsy

Dr. Jocelyn Rapelyea, Associate Director of Breast Imaging and Intervention at George Washington University Medical Center in Washington, D.C., demonstrated how occult lesions identified with Breast-Specific Gamma Imaging (BSGI) can be localized utilizing multi-modality imaging for needle biopsy as well, as for pre-operative localization today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

Medical News

Radiologist reports 90% radiation reduction in new cardiac CT scanners

NAF and Bristol-Myers Squibb take initiative to launch 'Positive Charge'

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

NuGEN Technologies launches its next generation Ovation RNA-Seq System

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

nContact Surgical initiates clinical trials of its convergent procedure for paroxysmal AF

Educational resource guide about pharmaceutical industry practices released

Health Sciences Group announces positive feedback from Medical Marijuana

Development of novel virus can lead to new therapeutic strategy to combat cancer

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

Study reveals current cleaning methods can do more harm than good to school environments

Cyber Monday was the best day ever, announces drugstore.com

Careful diagnosis can help avoid long-term disabilities associated with uncommon fractures

Genzyme ships vials of newly produced Cerezyme

Roche announces results of phase III taspoglutide study in diabetes patients

Pharmacists provide strategies to minimize disruption on common prescription drugs

Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

Bioactive sponge to eliminate normally fatal tumors

Infections remain a common problem in ICU patients

Occult lesions identified with BSGI can be localized using multi-modality imaging for needle biopsy

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News